ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients

Podobne zapisy

• Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
  od: Rawan ElAbd, i wsp.
  Wydane: (2021-03-01)
• Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
  od: Dorcas Beaton, i wsp.
  Wydane: (2023-11-01)
• ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
  od: Ivan T. Lee, i wsp.
  Wydane: (2020-10-01)
• Sacubitril/Valsartan vs ACE Inhibitors or ARBs
  od: Endurance Evbayekha, MD, i wsp.
  Wydane: (2025-03-01)
• Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
  od: J. Spinar, i wsp.
  Wydane: (2009-08-01)